Loera S - Search Results

1

Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.

Figarola JL, Scott S, Loera S, Xi B, Synold T, Weiss L, Rahbar S. Figarola JL, et al. Among authors: loera s. Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):533-44. doi: 10.1002/dmrr.550. Diabetes Metab Res Rev. 2005. PMID: 15818713

2

Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.

Figarola JL, Scott S, Loera S, Xi B, Synold T, Rahbar S. Figarola JL, et al. Among authors: loera s. Ann N Y Acad Sci. 2005 Jun;1043:767-76. doi: 10.1196/annals.1333.089. Ann N Y Acad Sci. 2005. PMID: 16037304

3

LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Figarola JL, Scott S, Loera S, Tessler C, Chu P, Weiss L, Hardy J, Rahbar S. Figarola JL, et al. Among authors: loera s. Diabetologia. 2003 Aug;46(8):1140-52. doi: 10.1007/s00125-003-1162-0. Epub 2003 Jul 5. Diabetologia. 2003. PMID: 12845431

4

LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat.

Figarola JL, Loera S, Weng Y, Shanmugam N, Natarajan R, Rahbar S. Figarola JL, et al. Among authors: loera s. Diabetologia. 2008 May;51(5):882-91. doi: 10.1007/s00125-008-0935-x. Epub 2008 Mar 4. Diabetologia. 2008. PMID: 18317729

5

Immunoglobulin light chain immunohistochemistry revisited, with emphasis on reactive follicular hyperplasia versus follicular lymphoma.

Weiss LM, Loera S, Bacchi CE. Weiss LM, et al. Among authors: loera s. Appl Immunohistochem Mol Morphol. 2010 May;18(3):199-205. doi: 10.1097/PAI.0b013e3181c59a81. Appl Immunohistochem Mol Morphol. 2010. PMID: 20042853 Free PMC article.

6

Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.

Chu PG, Loera S, Huang Q, Weiss LM. Chu PG, et al. Among authors: loera s. Am J Clin Pathol. 2006 Oct;126(4):534-44. doi: 10.1309/3WG32YRAMQ7RB9D4. Am J Clin Pathol. 2006. PMID: 16938666

7

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.

Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG. Coston WM, et al. Among authors: loera s. Am J Surg Pathol. 2008 Mar;32(3):433-44. doi: 10.1097/PAS.0b013e318158142f. Am J Surg Pathol. 2008. PMID: 18300806

8

Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.

Chung L, Lau SK, Jiang Z, Loera S, Bedel V, Ji J, Weiss LM, Chu PG. Chung L, et al. Among authors: loera s. Am J Surg Pathol. 2009 Nov;33(11):1594-600. doi: 10.1097/PAS.0b013e3181accb01. Am J Surg Pathol. 2009. PMID: 19574885

9

Biomarker identification with ligand-targeted nucleoprotein assemblies.

Singer EM, Crocitto LE, Choi Y, Loera S, Weiss LM, Imam SA, Wilson TG, Smith SS. Singer EM, et al. Among authors: loera s. Nanomedicine (Lond). 2011 Jun;6(4):659-68. doi: 10.2217/nnm.11.22. Nanomedicine (Lond). 2011. PMID: 21718176 Free PMC article.

10

Antitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironment.

Liang W, Kujawski M, Wu J, Lu J, Herrmann A, Loera S, Yen Y, Lee F, Yu H, Wen W, Jove R. Liang W, et al. Among authors: loera s. Clin Cancer Res. 2010 Feb 1;16(3):924-35. doi: 10.1158/1078-0432.CCR-09-1486. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters